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CHARACTERIZATION OF FRACTURE HEALING IN MYOCARDIN? 
RELATED TRANSCRIPTION FACTOR?A DEFICIENT MICE 
BENJAMIN PARKER 
ABSTRACT 
Introduction: A recent area of interest has become adipose tissue of the bone marrow. 
Unlike fat found elsewhere in the body, it is able to respond to its microenvironment by 
expanding, contracting, and even releasing hormones of its own. The marrow adipose 
tissue (MAT) increases with age and even within anorexic patients. Changes in MAT 
may be directly linked to bone tissue, since both adipocytes and osteoblasts share a 
common progenitor cell population. This is supported by recent results showing that the 
constitutive deletion of the MRTF-A (Myocardin related transcription factor A) gene not 
only led to leaner mice leaner but also had a  bone phenotype. The bones were shorter 
and had decreased bone mass; the female mice were more susceptible to osteopenia. It is 
unclear as to how this bone phenotype will respond to fracture repair, a coordinated 
process that is dependent upon differentiation toward the osteoblast lineage. Therefore, 
both male and female MRTF-A knockout (KO) and wild type (WT) mice were examined 
in a fracture study.    
Methods: Male and female mice (KO and WT) aged 8-16 weeks were fractured using a 
closed, stabilized fracture model. Tissues were harvested as post-operative day 14, 21, 
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and 37.  Radiographic films and histological assessment were completed at each time 
point to visualize  the progression of fracture repair. Gene expression studies using RT-
qPCR were all done at time points 14 and 37. Results were compared between genotype 
and sex.  
Results: Fracture calluses between WT and KO male and female mice appeared nearly 
identical via X-ray, suggesting that MRTF-A did not affect fracture repair. Only at the 
later time points did the histology show females had increased MAT regardless of 
genotype. Immunofluorescence with perilipin further confirmed this. Adipogenic, 
chondrogenic, and osteogenic markers also yielded differences in relative mRNA 
expression between the sexes. 
Conclusions: The MRTF-A KO mice did not show delayed or altered fracture repair 
compared to the WT mice. However, the  data suggest difference in MAT deposition 
between male and female mice. Further work is necessary to fully understand this sex 
difference. 
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INTRODUCTION 
 
Bone and fat  
Bone and fat are now considered key components of the endocrine system. Bone 
secretes important hormones and receptors that regulate metabolism in the form of 
osteocalcin and G-protein coupled receptors, respectively. While fat secretes adipokines, 
signaling molecules of adipocytes, that regulate glucose and fatty acid metabolism. There 
exists important crosstalk between the osteoblasts and adipocytes since leptin is able to 
influence osteocalcin’s bioactivity (Lenders et al. 2013). The bone marrow contains 
adipocytes and this is called marrow adipose tissue (MAT). Marrow fat is more than just 
an energy reservoir, however, as it contains important stem cells and chemokines. MAT 
is effectively an endocrine organ because it is able to respond to the local and systemic 
changes by regulating the production of adiponectin and leptin. Patients with anorexia see 
an increase in their circulating levels of adiponectin. 
 
Clinically, MAT is important because patients that are anorexic, obese, 
osteoporotic, and older see an increase in their MAT (Scheller 2016). Anorexic patients, 
for example, suffer from decreased body weight but the caloric restriction, i.e., dieting, 
actually triggers MAT to expand. Interestingly, adipocytes and bone cells, osteoblasts, 
share the same progenitor, mesenchymal stem cell (MSC). Note that initially the MSC 
has an equal chance of becoming an osteoblast or adipocyte. However, once the MSC 
differentiates into fat or bone, it cannot switch between its chosen cellular fate. 
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Depending on the external environment of the MSC, the MSC is selected for an 
osteoblast or adipocyte lineage (Coelho et al. 2013). Runx2 selectively upregulates the 
osteoblastic fate while repressing the adipocyte lineage. Conversely, Peroxisome 
Proliferator-activator gamma (PPARγ) promotes an adipocytic fate while reducing the 
odds of osteoblastic differentiation (Berendsen and Olsen 2013). According to the 
National Osteoporosis Foundation, osteoporotic effects lead to $20 billion of health care 
costs each year and are growing. As well, anorexia leads to an additional $2000 cost to 
eating disorder patients (Samnaliev et al. 2015). Furthermore, with an aging population 
MAT’s importance is more relevant than ever. Thus, if MAT can be better understood, 
therapeutics may be developed to combat the aforementioned ailments, and curb their 
enormous financial burden to patients. 
 
Myocardin Related Transcription Factor-A (MRTF-A)  
In order to study molecular regulators of adipogenesis, MRTF-A was knocked out 
in a mouse model (Bian et al 2016). The phenotypes observed with the deletion of the 
MRTF-A gene included increased fat production and lowered bone mineral density in 
male and female mice. The osteopenia seen in MRTF-A KO mice was especially 
potentiated in younger mice fed on a high fat diet because 24-week males on a low fat 
diet and 12-week females on a high fat both exhibited the same levels of osteopenia. The 
apparent sex difference is the cornerstone for the ensuing investigation. 
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MRTF-A is a transcriptional co-activator, part of the Hippo pathway, and is 
regulated through its subcellular concentration by its interaction with G-actin. When G-
actin combines to form long filaments in the form F-actin, G-actin is effectively lowered 
thus increasing the free amount of MRTF-A able to bind to SRF (Olson and Nordheim 
2010). Further, nuclear G-actin is the predominant factor in controlling the MRTF-A SRF 
circuit activity (Vartiainen 2007). Once inside the nucleus, MRTF-A associates with the 
transcription factor SRF. SRF then binds to the CArG box and transcribes several 
proteins involved in cytoskeletal architecture. When a cell undergoes adipogenesis, the 
cell must also change its shape to accommodate the increased fat production. 
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Figure 1: MRTF-A Signaling Pathway: Adapted from Kuwahara et al. 2005 
Figure 1 illustrates in full detail the MRTF-A SRF pathway. Special focus should be 
placed on the central pathway. When G-actin is in association with MRTF-A it is unable 
to enter the nucleus. Similarly, while not shown, nuclear G-actin is capable of impeding 
MRTF-A from binding to SRF. 
 
Since MRTF-A knockout mouse resulted in an osteopenic phenotype it suggested 
that the MSC is directed toward the adipogenic lineage at the expense of the osteoblast 
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lineage. In order to determine whether this hypothesis was correct, this study challenged 
the animals using a fracture model. This model is advantageous since during fracture 
repair there is a recruitment of stem cells followed by differentiation.    
 
Fracture Healing 
Fracture healing is a complex, multi-step process (Figure 2).  The first phase of 
fracture healing is inflammation: the key components are blood, cytokines, and 
antibodies that rush to the site of injury. The blood’s origin is from periosteal vessels, and 
serves to create a hemostatic plug. The plug also serves as a beacon for signaling, with 
the recruitment of local periosteal stem cells to the area of injury. Additionally, the 
presence of oxygen within the blood dictates what cells are found in each region. For 
example, near the injury site, where there is greater oxygen, bone formation is more 
likely to take place. Conversely, near the periphery, where oxygen tension is low, there is 
an abundance of cartilage (Lu et al. 2013). 
 
After about two days, the reparative phase begins as the hematoma granulizes. It 
is now known as a reparative granuloma. Revascularization from the main nutrient 
arterial vessels occurs along with cartilage being laid from chondroblasts. The 
chondroblasts create a layer of cartilage that acts as a template for bone to be laid upon. A 
soft callus filled with fibrocartilage forms. After the cartilage model is finished, the soft 
callus mineralizes due to increased alkaline phosphatase activity as the pH increases.  
Osteoclasts degrades the cartilage while osteoblasts generate new bone.  
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The last phase of fracture healing is the remodeling phase, which occurs about three to 
four weeks outside of injury. Primary remodeling involves osteoblasts that lay down bone 
to harden the callus while secondary remodeling incorporates osteoclasts that remove 
bone in an attempt to restore the bone’s native structure. 
 
 
Figure 2: Fracture Model via X-rays: The black bars represent the average period where each stage is 
optimally occurring. Adapted from Bragdon et al. 2015 
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SPECIF?C AIMS 
 
Aim 1: To further investigate the connection between bone and fat using a closed, 
stabilized, animal fracture model of both WT and MRTF-A KO mice. 
Aim 2: Examine sex difference during fracture repair.  
Aim 3: Examine sex differences in adipose tissue deposition in the bone marrow  of mice 
through histology, immunofluorescence, and qPCR. 
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METHODS 
Materials 
The primary antibody used for immunofluorescence (IF) was Perilipin, D1D8, 
XP® Rabbit from Cell Signaling Technology® (Danvers, MA). The secondary antibody 
was Invitrogen Alexa Fluor 488 anti-rabbit dye. ProLong gold-antifade reagent with 4',6-
diamidino-2-phenylindole (DAPI) was used for mounting IF stained slides. The dental 
films are from Carestream Dental (Atlanta, GA).  Kodak Biomax XAR Scientific 
Imaging Films (Rochester, NY) and Denville Scientific HyBlot ES™ autoradiography 
films (Holliston, MA) were used to take X-rays. Permount® Mounting Medium was used 
for Hematoxylin and Eosin (H&E) as well as Fast Green and Safranin-O (FG & Saf-O) 
stained slides. Fisher Healthcare™ Tissue-Plus&treg; O.C.T. Compound was used to 
embed tissue samples. The SeaKem® LE agarose and GelStar™ Nucleic Acid Gel Stain 
used for gel electrophoresis are from Lonza (Basel, Switzerland). All reagents used for 
cDNA collection as well as primers used for quantitative PCR (qPCR) were from 
Applied Biosystems (Foster City, CA). All other materials, unless noted otherwise, are 
from Thermo Fisher Scientific (Suwanee, GA) 
 
Animals 
All animal studies performed were approved by The Institutional Care and Use 
Committee of Boston University (BU). The transgenic mice, MRTF-A KO and WT, were 
kindly provided by Dr. Stephen Farmer at BU. These mice were originally created by Dr. 
Olson from UT Southwestern Medical Center. Animals were housed in standard 
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conditions. Both male and female mice aged 8-16 weeks were used for this study. 
Ultimately, a total of 51 mice were used: day 14 males (n=9), day 14 females (n=6), day 
21 males (n=6), day 21 females (n=3), day 35 males (n=10), day 35 males (n=7), day 37 
males (n=5), and day 37 females (n=3). 27 of the mice were used for RNA analysis and 
39 for histology. 
 
Fracture 
Closed stabilized femoral fractures were created according to the procedure outlined in 
Lybrand et al. 2015. Anesthesia was induced in a closed chamber with 4% 
isofluorane/oxygen mixture. Once induced, 2% isofluorane was administered via a 
nosecone throughout surgery. The  surgical site was prepared by removing fur with 
clippers and cleaning skin with betadiene.   Buprenex (0.1 mL) and Baytril (0.01 mL) 
were injected to mitigate pain and prevent infection, respectively. Incisions were made 
using a #15 scalpel to expose the distal femur for intramedullary pin insertion. A 27 x ½ 
in Tuberculin (TB) syringe was used to make a hole for inserting an intramedullary pin 
with a 25 gauge spinal needle. The site was closed using 5-0 suture. The fracture device, 
as described by Marturano et al. 2008, was used to generate closed fractures by blunt 
trauma (Marturano et al., 2008). A dental X-ray machine (70 kV for 5 seconds) was used 
to confirm fracture. Post-operative care was provided and it involved checking on the 
mice for the next 48 hours for pain management with Buprenex and for any 
complications, e.g.., infection or open wounds.  
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Harvest 
Animals were euthanized at days 14, 21, 35, and 37 post-surgery using CO2 followed by 
cervical dislocation. All fractures were imaged using the Faxitron X-ray Specimen 
Radiography System MX-20. Settings used were 30 kV for 40 seconds. At time of 
harvest the intramedullary pins were removed. For histological samples, the femur and 
surrounding muscle were kept intact. The muscle was removed from the fracture for the 
RNA samples. Both muscle and fracture tissues were snap frozen with liquid nitrogen 
and stored at -80°C.    
 
Histology 
Histological analysis was performed according to the procedures in Gerstenfeld et al. 
2006. Tissue was collected and fixed in 4% PFA w/v for 1-2 days before placing in 14% 
w/v EDTA for decalcification for about two weeks at 4˚C. Decalcification was confirmed 
by inserting a 25 gauge needle through the boney tissue.  Samples were separately 
prepared for frozen sectioning or paraffin embedding sectioning.  For frozen sectioning, 
decalcified specimens were washed with Phosphate-buffered saline (PBS) and placed into 
a 7.5% sucrose/PBS solution on a shaker for an hour. After the hour, the samples were 
put into a solution of 30% sucrose/PBS overnight. The next day, the samples were 
covered with half 30% sucrose/PBS and half OCT for overnight. The samples were then 
frozen by placing them into plastic molds and carefully covering them in OCT to prevent 
the formation of bubbles. Once embedded in OCT, the mold was placed into a metal 
container filled with methylbutane floating atop liquid nitrogen. Specimens that were 
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paraffin embedded were placed in 70% ethanol after decalcification.  An automated 
procedure was used for paraffin embedding. All samples were sectioned at approximately 
7.5 μm. Prior to staining, frozen samples were washed with PBS for five minutes twice 
followed by staining. Paraffin samples underwent deparaffinization and rehydration via 
washing in pure xylene for 3 min and repeating three times followed by incubations in 
100% ethanol (EtOH) for 5 min, followed by another 2 min in 100% EtOH, 2 min in 95% 
EtOH, and 75% EtOH for 2 min. The slides were then placed in distilled water for 5 min. 
Staining was completed using standard procedures for Hematoxylin and Eosin (H&E) 
and  Fast Green and Safranin-O (FG & Saf-O). Finally, the slides were allowed to air dry 
and coverslipped using Permount®. 
 
  
 
Immunofluorescence (IF) 
IF was carried out on deparaffinized and rehydrated sections using an identical protocol 
as described above for standard histological processing.  After rehydration antigen 
retrieval was performed using an antigen unmasking solution (3 mL of unmaking solution 
to 317 mL of dH2O) and heat. Samples were microwaved for 5 minutes at a power 
setting of 4. After 5 minutes, the solution was allowed to cool for a minute with the 
microwave door open. Another 5 minutes of microwaving was done at a power of 3 
followed by cooling and repeated heating. The specimens were then blocked using a 
blocker buffer consisting of 1x PBS, 5% Fetal Bovine Serum, and .1% Triton X-100 for 
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60 minutes to prevent any unwanted signal. The blocking buffer was then removed and 
samples were washed three times with 1x PBS.  The primary antibody, Perilipin, was 
diluted 1:200 using an antibody dilution buffer composed of 1x PBS, 1% Bovine Serum 
Albumin, and 0.1% Triton X-100. After washing with 1x PBS, three times, about 80 
microliters of the diluted primary antibody was applied to the experimental specimens 
and incubated overnight at 4˚C. The following morning, the specimens were rinsed again 
with 1x PBS, repeated three times each. The secondary antibody, Invitrogen Alexa Fluor 
488 anti-rabbit dye, was diluted 1:2000 with the antibody dilution buffer and was applied 
to all specimens for an hour and half at room temperature in the dark. Another wash with 
1x PBS, three times, was done to remove any superfluous secondary antibody. Finally, 
the slides were coverslipped using the ProLong gold-antifade reagent with DAPI and 
allowed to cure overnight at room temperature while protected from light. 
 
Imaging 
The Olympus BX51 microscope was used for all imaging purposes. H&E and FG & Saf-
O slides were imaged using the brightfield microscopy filter. IF stained slides were 
imaged using a special filter to detect DAPI and one to detect “GFP” since it is 
approximately the same wavelength as the secondary antibody. Stitched images were 
taken at 10x and 20x using the cellSens Dimension software. 
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RNA 
 
The RNA was extracted from the fracture callus by placing sample into 750 μl of Trizol 
reagent and snap frozen using liquid nitrogen. A metal bead was then dispensed into the 
tube and samples were lysed using a tissue lyser set at  30 Hz for two minutes. In general, 
an additional minute had to be used to fully lyse the bone. Additional  1mL of Trizol was 
added to the sample and left on ice for at least 2 minutes. Chloroform (200 μl)  was then 
added to each sample.  Next, the samples were vortexed until a homogeneous mixture 
resulted. The samples were then placed on ice again for another 2 min before centrifuging 
for 15 min at 4˚C and 15,000 rpm. The top, clear layer was removed, avoiding 
contamination with Trizol. An equal amount (1:1 ratio) of isopropanol was added to the 
samples and centrifuged at the same settings as before but for 30 min. The supernatant 
was removed from the white pellet and 500 μl of 70% ethanol was added and centrifuged 
for 5 min at 4˚C and 15,000 rpm. The pellet was washed a second time.  After discarding 
the ethanol, the samples were left to dry.  When the pellets appeared translucent, usually 
about 30 min to an hour, 50 μl of UltraPure DNase/RNase-Free distilled water (dH2O) 
was added to dissolve the pellet. An agarose gel was run to confirm quality of mRNA by 
the visualization of 18S and 28S ribosomal RNA subunits.  
 
 
cDNA 
Total RNA (2 μg) was converted to cDNA using the Taqman Reverse Transcription kit, 
according to Femia 2015. The reaction settings were set as following:  25 ˚C for 10 min, 
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37 ˚C for 60 min, 95 ˚C for 5 min, and held at 4˚C. The cDNA was diluted 1:50 with 
UltraPure DNase/RNase-free dH2O and stored at -20 ˚C. 
 
qRT-PCR 
A primer mix was made by adding 600 μl of Universal Master Mix and 60 μl of the 
primer set. Table 1 lists all primers used for this study. Each well of a 96 well plate 
received 11 μl followed by 9 μl of diluted cDNA. Each sample was run in duplicate.  A 
negative control was also included, which consisted of water. The 7300 System SDS RQ 
Study Software with v1.4 Software Upgrade Kit was used to quantify the RT-PCR 
reactions. Normalization was done by taking the average of the cycle threshold (Ct) 
values for the housekeeping gene, 18S rRNA, and then subtracting that from the average 
of the gene of interest for the difference Ct value (dCt). The relative mRNA expression 
was then calculated by 2−𝑑𝐶𝑡. 
Table 1: qPCR Primers 
 
 
Gene Name Assay ID Purpose 
18S Mm04277571_s1 
 
Normalization 
MRTFA1 Mm00461840_m1 
 
KO validation 
Perilipin1 
(PLIN1) 
Mm00558672_m1 
 
Adipogenic 
Primer 
PPARγ Mm00440940_m1 
 
Adipogenic 
Primer 
Aggrecan 
(ACAN) 
Mm00545794_m1 
 
Chondrocytic 
Primer 
SRY-box 
containing gene 
9 (SOX9) 
Mm00448841_m1 
 
Chondrocytic 
Primer 
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Dentin Matrix 
Phosphoprotein 
1 (DMP1) 
Mm01208363_m1 
 
Osteoblastic 
Primer 
Bone Gamma-
carboxylglutamic 
acid-containing 
protein 
(BGLAP) 
Mm00649782_gh 
 
Osteoblastic 
Primer 
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RESULTS 
 
 
 
Radiological Assessment of Fracture Healing 
 
It was recently determined that MRTF-A is a key regulator of adipogenesis. 
Interestingly, mice with the deletion of the MRTF-A gene not only had a lower whole 
body weight but also developed osteopenia or decreased bone mass. It was suggested that 
this phenotype was due to the bone marrow stromal cells of the KO having a greater 
differentiation potential toward adipocytes compared to osteoblasts. During fracture 
repair, stem cells are recruited to the site for the fracture, and must differentiate toward 
the osteogenic lineage for proper bone healing. The bone marrow that reconstitutes after 
fracture also has higher numbers of adipocytes than marrow from unfractured mice.  This 
would suggest that the large number of stem cells that re-recruited during injury response 
may be redirected in part the adipogenic lineage.  In order to further investigate this 
mechanism, a closed, stabilized fracture was created in the femur of the MRTF-A KO 
mice and compared to the WT.  
Both male and female mice were enrolled due to the differences observed within 
the MRTF-A KO mice, the females showed increased bone mass loss compared to males. 
The fracture callus was harvested at post-operative days (POD) 14, 21, 35, and 37. All 
samples were imaged with radiographic film followed by fixation, demineralization, and 
histology. Figures 3 and 4 show that fractures of both WT and KO male and female mice 
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healed by POD 37. However, some of the MRTF-A KO calluses appeared larger when 
compared to the WT.  
 
The MRTF-A KO Mice Show Normal Fracture Repair  
 
 
Females 
 
 WT KO 
D
ay
 1
4
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Figure 3: Representative X-rays of female fracture calluses  
 
Figure 3 shows that all fractures of males healed properly, as there’s no indication of 
delay or union. The female KOs show definitively larger fracture calluses at each time 
point. 
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Males 
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Figure 4: Representative X-rays of  male fracture calluses 
 
The male fractures also all show properly healed fractures, with no signs of union or 
delay. Remarkably, the male KOs’ fracture calluses appear only slightly larger than their 
WT counterparts. 
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Histological and Immunohistological Examination of Fat Accumulation  
During Fracture Healing  
 
 
Figure 5: FG & Saf-O POD 21 female WT 10x magnification. The black bar represents 1 mm and 
the two black arrows draw attention to the outer callus. 
 
 
Figure 5 shows a fracture callus of a female WT at POD 21. It clearly shows cartilage, 
stained red-orange, at the fracture line. The bone, stained in blue, shows bridging of the  
callus and near the center bone remodeling is seen with both woven and lamellar bone.  
Some adipocytes are observed within the outer callus, as pointed out by the two black 
arrows. 
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Histological and Immunohistological Examination of Fat Accumulation 
ring  racture Healing  
 
 
Figure 5: FG & Saf-O POD 21 female WT 10x magnification. The black bar represents 1 mm and the 
two black arrows draw attention to the outer callus. 
 
Figure 5 shows a fracture callus of a female WT at POD 21. It clearly shows cartilage, 
stained red-orange, at the fracture line. The bone, stained in blue, shows bridging of the 
callus and near the center bone remodeling is seen with both woven and lamellar bone. 
Some adipocytes are observed within the outer callus, as pointed out by the two black 
arrows.  
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Figure 6: FG & Saf-O POD 21 female KO 10x magnification. The black bar represents 1 mm and the 
black arrow indicates the outer callus 
 
By POD 21, the fracture callus of the KO female mice showed bridging and bone 
remodeling. However, adipocytes are also observed within the outer fracture callus.  
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Figure 6: FG & Saf-O POD 21 female KO 10x magnification. The black bar represents 1 mm and the 
black arrow indicates the outer callus 
 
By POD 21, the fracture callus of the KO female mice showed bridging and bone 
remodeling. However, adipocytes are also observed within the outer fracture callus.  the 
fracture callus in  
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Figure 7: FG & Saf-O POD 35 female WT 10x magnification. The black bar represents 1 mm 
 
The fracture callus in the bone marrow contains prodigious amounts of MAT, and the 
fracture callus has a significant amount of adipocytes as well. 
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Figure 7: FG & Saf-O POD 35 female WT 10x magnification. The black bar represents 1 mm 
 
The bone marrow contains prodigious amounts of MAT, and the fracture callus has a 
significant amount of adipocytes as well. 
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Figure 8: FG & Saf-O POD 35 female KO 10x magnification. The black bar represents 1 mm and the 
black arrow points to the outer callus region. 
 
 
Figure 8 shows the female KO callus at POD 35. Although adipocytes are observed 
within the repaired fracture callus, it appears to be decreased compared to the WT. 
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Figure 8: FG & Saf-O POD 35 female KO 10x magnification. The black bar represents 1 mm and the 
black arrow points to the outer callus region. 
 
Figure 8 shows the female KO callus at POD  35. Although adipocytes are observed 
within the repaired fracture callus, it appears to be decreased compared to the WT.  
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Male WT and KO Comparison 
 
Figure 9: FG & Saf-O day 21 male WT 10x magnification. The black bar represents 1 mm. 
 
 
Figure 9 shows a significant amount of remodeling in the marrow cavity with adipocytes 
in the outer callus. 
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ale T and KO Comparison 
 
 
Figure 9: FG & Saf-O day 21 male WT 10x magnification. The blackbar represents 1 mm. 
 
Figure 9 shows a significant amount of remodeling in the marrow cavity with adipocytes  
in the outer callus 
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Figure 10: FG & Saf-O day 21 male KO 10x magnification with the black line in the bottom-right corner 
representing 1 mm 
 
 
Figure 10 shows the corresponding KO for day 21. Copious cartilage can be seen in the 
marrow cavity near the fracture line. There’s almost no fat compared to the WT. 
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Figure 11: FG & Saf-O POD 35 male WT 10x magnification. The black bar represents 1 mm and the 
black arrows point to the marrow and callus regions. 
 
 
Figure 11 shows lots of adipocytes in the marrow space and a callus can be seen bulging 
in the center downwards. 
 
 
Figure 12: FG & Saf-O POD 35 male KO 10x magnification with the black line in the bottom-right 
corner representing 1 mm 
 
The striking feature of Figure 9 is the adiposity in the outer callus compared to the bone 
marrow; there are much more adipocytes in the outer callus than the marrow. 
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Male and Female Mice Show Different Callus and Marrow Adiposity at Later Time 
Points 
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Figure 13: Sex Comparison of Callus and Marrow Adiposity at POD 21 
 
No differences were observed between male and female mice at POD 21; both show 
fracture repair and small numbers of adipocytes.  
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Figure 14: Sex Comparison of Callus and Marrow Adiposity at POD 35 
  
Table 14 shows that there is more adipocytes in the WT female compared to the male at 
POD 35. The KO male, however shows more fat than its female counterpart. 
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Demonstration of Varying levels of Adiposity in Three Compartments via 
Immunofluorescence with Perilipin 
  
Because the histology implied females having more fat at later time points, 
independent of genetic deletion, a perilipin antibody was used to tag the adipocytes of 
POD 35 male and female and WT and KO mice. Fracture healing involves not just the 
bone, but also the muscle and subcutaneous layer. Immunoanalysis was therefore carried 
out in the marrow space, subcutaneous layer, and musculature.  
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Bone Marrow Adiposity 
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Figure 15: Perilipin stained MAT at 10x magnification 
 
Figure 15 showcases that WT mice contain more MAT than KO mice. While it may 
qualitatively appear that female mice have more MAT than male mice, a quantitative 
measure must be used for confirmation. 
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Subcutaneous Adiposity 
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Figure 16: Perilipin stained subcutaneous adipocytes at 10x magnification 
 
From figure 16, it can be seen that the females have more fat than the males while there 
does not appear to be a difference between WT and KOs. 
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Intramuscular Adiposity 
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Figure 17: Perilipin stained intramuscular adipocytes at 10x magnification 
 
Figure 17 shows that the KO mice have much more adipocytes in the musculature 
compared to the WT. At this point in time, no conclusion can be made about a sex 
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difference. Further confirmation is needed with RNA to validate the existence of a 
possible sex difference. 
 
Molecular Analysis of mRNA Expression Across Fracture Healing 
  
In order to further support the idea that female mice contained more adipose 
tissue independent of the genetic deletion of MRTF-A, qPCR was carried out. qPCR also 
was used to confirm that MRTF-A was truly deleted in the KO mice. As a quantitative 
measure of the adiposity, adipogenic markers were used. Additionally, osteoblastic 
markers were included because there is mutual exclusivity between adipogenesis and 
bone formation. Chondrogenic markers were used to observe any differences in 
chondrogenesis. 
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Figure 18: MRTF-A KO validation via MRTFA1  
The qPCR data was normalized by calculating the ΔΔCt. The difference between the 
duplicate wells of 18S yielded the ΔCt. and this value was then subtracted from the 
duplicate wells of the gene of interest, e.g., MRTFA1. The data confirmed that the 
MRTF-A gene was deleted because the WTs for both males and females all reported 
greater mRNA expression. 
 
 
 
Figure 19: Adipogenesis via PPARγ 
Generally, figure 38 demonstrates that PPARγ levels were consistently low for day 14 
and then increased significantly at day 37. The female KO actually decreased compared 
to its earlier time point. PPARγ was chosen because it provides an assay for adipogenesis 
throughout time points. 
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Figure 20: Adipogenesis via PLIN1 
 
PLIN1 is a gene that is involved in lipid droplets. The perilipin stain done earlier detected 
the presence of these lipids. In figure 35, PLIN1 expression is initially low and then 
increases at the later time points. 
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Figure 20: Adipogenesis via PLIN1 
PLIN1 is a gene that is involved in lipid droplets. The perilipin stain done earlier detected 
the presence of these lipids. In figure 35, PLIN1 expression is initially low and then 
increases at the later time points.  
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Figure 21: Chondrogenesis via SOX9 
 
 
SOX9 is important for chrondrocytic lineage commitment, and acts as a critical 
transcription factor of Col2a1. Figure 39 shows that SOX9 expression levels are higher in 
the earlier time points and then decrease dramatically later on, save for the female KO, 
which hovered around the same value. 
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Figure 21: Chondrogenesis via SOX9  
 
SOX9 is important for chrondrocytic lineage commitment, and acts as a critical 
transcription factor of Col2a1. Figure 39 shows that SOX9 expression levels are higher in 
the earlier time points and then decrease dramatically later on, save for the female KO, 
which hovered around the same value. 
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Figure 22: Chondrocytic lineage commitment via ACAN 
 
 
ACAN is an early marker of chondrocytic differentiation. Figure 22 shows that ACAN 
levels are high for the day 14’s and then drop precipitously at day 37. 
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Figure 22: Chondrocytic lineage commitment via ACAN 
ACAN is an early marker of chondrocytic differentiation. Figure 36 shows that ACAN 
levels are high for the day 14’s and then drop precipitously at day 37. 
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Figure 23: Osteoblastic Differentiation via Osteocalcin 
 
 
Osteocalcin is secreted by osteoblasts for their maturation. From figure 23, osteocalcin 
expression levels appear to be nearly identical across the different genotypes and sexes at 
the early time point. At the later time point, there is a noteworthy increase for the female 
KO while the male WT paradoxically decreases 
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Figure 23: Osteoblastic Differentiation via Osteocalcin 
 
Osteocalcin is secreted by osteoblasts for their maturation. From figure 37, osteocalcin 
expression levels appear to be nearly identical across the different genotypes and sexes at 
the early time point. At the later time point, there is a noteworthy increase for the female 
KO while the male WT paradoxically decreases. 
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Figure 24: Osteoblastic differentiation via DMP1 
 
 
DMP1 is a marker for osteoblastic maturation. Figure 24 congruently displays that DMP1 
levels fall with time. The female KO does decrease, although only marginally. 
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Figure 24: Osteoblastic differentiation via DMP1 
DMP1 is a marker for osteoblastic maturation. Figure 40 congruently displays that DMP1 
levels fall with time. The female KO does decrease, although only marginally. 
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DISCUSSION 
The decision to include both sexes in this study was made based on the findings 
of Bian et al 2016, which demonstrated that females were more susceptible to the 
osteopenic phenotype at earlier time points. The X-rays (Figures 3 & 4) suggest that the 
deletion of MRTF-A does not impact fracture repair. Concerning histology, while there 
were no observable differences in marrow adipose tissue (MAT) deposition at day 21 
(Figure 13) at day 35 (Figure 14), the trend appeared to show that both WT and KO 
females contained more marrow fat than any other group.  The IF serial sections provided 
further proof of fat’s existence within the three pertinent compartments: bone marrow, 
muscle, and subcutaneous layer. Once confirmed, qPCR analysis was done to quantify 
the relative mRNA expression levels. The MRTF-A gene deletion was first validated 
(Figure 18) before carrying out additional qPCR analysis of important markers of 
adipocytic, chondrocytic, and osteoblastic differentiation. PPARγ mRNA and PLIN1 
expression levels, as a whole, show that their expression increases with time for both 
sexes and genotypes (Figures 19 & 20). The female KO’s mRNA expression levels 
decreased for PPARγ with time (Figure 19), but there is considerable standard error for 
those data.  
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In regards to chondrocytic differentiation, both  SOX9 and ACAN mRNA 
expression levels decreased with time, an expected result (Figures 21 & 22). What is 
interesting, however, is that the female KO’s ACAN and SOX9 mRNA expression levels 
barely dropped compared to the rest of the experimental groups. The osteoblastic 
differentiation qPCR data for DMP1 was as expected (Figure 24) while the results for 
osteocalcin are rather puzzling (Figure 23). Osteocalcin mRNA expression levels for the 
female KO increased remarkably compared to all other experimental groups.  
There is clearly a sex difference in deposition at later time points, most likely due 
to PPARγ, as it mirrors the trend. Further research is needed to fully define this apparent 
sex difference in MAT deposition. The implications from the qPCR data are not 
compelling alone, though, especially because of the high standard error. These errors 
might have arisen both in relationship to the normalization data for 18S rRNA or 
technical issues with the execution of the RT-PCR reactions themselves. In this regard, Ct 
values for the 18S rRNA were much larger than normally observed for intact RNAs.  
Additional replicates should be carried out to correct these limitations. Another limitation 
of the qPCR analysis was the amount of mice included in each group. There were only 
two mice for the day 14 male WT and day 37 female WT. Adding another mouse to each 
group would provide for more robust statistics.  
In summary, female mice contain more adipose tissue than males independent of 
the knockout. The conclusion is supported both by histology and qPCR. Further, 
immunofluorescence with perilipin showed that there is greater fat in all three 
compartments in response to injury of female mice. A possible explanation for this 
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phenomenon is that fat is used as an energy source for fracture repair. Another 
explanation is that there is an abundant amount of stem cells recruited, and that they are 
predisposed to the adipogenic lineage. 
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